TL;DR: The Centers for Medicare & Medicaid Services modified NCD 228, the National Coverage Determination governing Medicare coverage of air-fluidized beds for home use, effective March 7, 2026. Here's what changes for billing teams.
CMS's coverage policy under NCD 228 sets strict medical necessity requirements for home air-fluidized bed reimbursement — and the criteria haven't gotten looser. This policy does not list specific HCPCS billing codes in the source document, but if your team bills for durable medical equipment (DME) in a home care or wound care context, this update touches your documentation requirements directly. Understand the criteria before March 7, 2026, or you're looking at claim denial exposure.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Centers for Medicare & Medicaid Services (CMS) |
| Policy | Air-Fluidized Bed |
| Policy Code | NCD 228 |
| Change Type | Modified |
| Effective Date | March 7, 2026 |
| Impact Level | High |
| Specialties Affected | Wound care, home health, DME suppliers, long-term care, plastic surgery, general surgery |
| Key Action | Audit your documentation for every active air-fluidized bed claim to confirm it meets all eight medical necessity criteria before March 7, 2026 |
CMS Air-Fluidized Bed Coverage Criteria and Medical Necessity Requirements 2026
NCD 228 is the National Coverage Determination governing whether Medicare will reimburse for home use of an air-fluidized bed — a device that uses warm pressurized air to set ceramic beads in motion, distributing a patient's body weight across a large surface area to reduce pressure ulcer progression. Coverage has been available for services rendered on or after July 30, 1990, but the medical necessity criteria are exacting and unforgiving.
Medicare payment under this coverage policy requires that every one of the following conditions is met simultaneously. Missing a single criterion isn't a documentation gap — it's a denial waiting to happen.
The eight required criteria:
| # | Covered Indication |
|---|---|
| 1 | Wound severity: The patient has a stage 3 (full thickness tissue loss) or stage 4 (deep tissue destruction) pressure sore. Stage 1 and stage 2 ulcers don't qualify. Period. |
| 2 | Mobility status: The patient is bedridden or chair-bound as a result of severely limited mobility. |
| 3 | Institutionalization threshold: Without the air-fluidized bed, the patient would require institutionalization. This is a high bar — and CMS expects documentation to support it explicitly. |
| 4 | Physician order with documented evaluation: The attending physician orders the bed in writing, based on a comprehensive assessment after a course of conservative treatment. That conservative treatment must have been at least one month in duration without measurable progression toward wound healing. The 30-day prerequisite can include institutional time, but the records have to verify conservative treatment was actually rendered there. |
| 5 | Caregiver availability: A trained adult caregiver is present and able to assist with activities of daily living, fluid balance, dry skin care, repositioning, dietary needs, prescribed treatments, altered mental status management, and direct management of the air-fluidized bed system — including troubleshooting leaks. |
| 6 | Ongoing physician oversight: The treating physician directs the home treatment regimen and reevaluates and recertifies medical necessity for the bed on a monthly basis. Monthly. Not quarterly, not at 90 days — every month. |
| 7 | Alternative equipment ruled out: All other alternative equipment has been considered and specifically ruled out. Your documentation needs to reflect this, not just assert it. |
| 8 | Conservative treatment completed: The required course of conservative treatment must include frequent repositioning (typically every two hours), a Group II specialized support surface, wound infection treatment, nutrition optimization, debridement by any means, and maintenance of a moist wound bed with appropriate occlusive dressings. |
One clarification worth understanding on the debridement issue: wet-to-dry dressings started during the conservative treatment period and continuing beyond 30 days won't block coverage. If debridement is needed again after the patient is already on the air-fluidized bed, that won't make the bed non-covered either — but documentation of continued need must be present and current.
Prior authorization requirements are not explicitly addressed in the NCD 228 policy language itself, but your DME Medicare Administrative Contractor (MAC) may impose prior authorization at the local level. Confirm with your MAC before billing.
CMS Air-Fluidized Bed Exclusions and Non-Covered Indications
This is where a lot of claims fall apart. CMS is direct about when home air-fluidized bed use is not covered, and the exclusions are clinically grounded — which makes them defensible, but also makes them disqualifying when present.
Home air-fluidized bed use is not covered under any of the following circumstances:
| # | Excluded Procedure |
|---|---|
| 1 | Coexisting pulmonary disease. The lack of firm back support makes coughing ineffective, and inhalation of dry warm air thickens pulmonary secretions. If the patient has significant pulmonary disease, this bed isn't just non-covered — it's potentially harmful. |
| 2 | Wet soaks or moist wound dressings not protected by an impervious covering. If the treatment protocol requires open wet wound care without occlusive protection like plastic wrap or other impervious material, the bed isn't covered. |
| 3 | Caregiver unwilling or unable to provide required care. If the caregiver can't or won't fulfill the full scope of responsibilities listed in criterion five above, coverage is off the table. |
The real issue here is documentation sequencing. Billing teams often flag these exclusions after a denial rather than screening for them before claim submission. Build a pre-submission checklist that explicitly verifies the absence of each exclusion criterion — not just the presence of the positive coverage criteria.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Stage 3 pressure sore (full thickness tissue loss), home use | Covered | No specific codes listed in NCD 228 | All eight criteria must be simultaneously met |
| Stage 4 pressure sore (deep tissue destruction), home use | Covered | No specific codes listed in NCD 228 | All eight criteria must be simultaneously met |
| Stage 1 or stage 2 pressure sore | Not Covered | — | Wound severity threshold not met |
| Patient with coexisting pulmonary disease | Not Covered | — | Explicit exclusion in NCD 228 |
| Wet soaks/moist dressings without impervious covering | Not Covered | — | Explicit exclusion in NCD 228 |
| No trained adult caregiver available | Not Covered | — | Explicit exclusion; caregiver capacity must be documented |
| Conservative treatment < 30 days or showing wound progression | Not Covered | — | Prerequisite treatment period not satisfied |
| All alternative equipment not yet considered/ruled out | Not Covered | — | Must document that alternatives were evaluated and eliminated |
| Institutionalization not required in absence of bed | Not Covered | — | Threshold for home coverage not met |
CMS Air-Fluidized Bed Billing Guidelines and Action Items 2026
These are the steps your billing team and DME suppliers need to take now, before March 7, 2026.
| # | Action Item |
|---|---|
| 1 | Audit every active air-fluidized bed claim for all eight criteria. Pull your current claims and chart documentation. Confirm stage 3 or stage 4 wound documentation, mobility status, institutionalization threshold justification, physician order with comprehensive evaluation, and the 30-day conservative treatment record — before March 7, 2026, not after a denial arrives. |
| 2 | Verify monthly physician recertification is happening. This is the most commonly missed requirement in air-fluidized bed billing. If your physician partners are recertifying quarterly or not at all, your reimbursement is at risk right now, regardless of this policy update. Set up a recurring workflow that triggers recertification requests 5–7 days before each monthly deadline. |
| 3 | Document caregiver capability explicitly. The policy doesn't just require a caregiver's presence — it requires documented ability and willingness to perform a specific list of tasks. Your intake and assessment forms should capture each task on that list by name, not just a general attestation that "caregiver is available." |
| 4 | Screen for exclusion criteria at intake, not at claim submission. Build a pre-billing checklist that includes pulmonary disease status, wound dressing type and whether occlusive protection is in place, and caregiver capacity. Catching an exclusion at intake saves time and avoids a denial cycle. |
| 5 | Confirm your MAC's prior authorization process. NCD 228 doesn't specify a prior authorization requirement, but your MAC may. Contact your DME MAC directly to confirm whether prior auth is required before placing the bed in the home. If you're not sure which MAC covers your jurisdiction, your compliance officer can point you to the right contact quickly. |
| 6 | Preserve and organize institutional conservative treatment records. When part of the 30-day prerequisite treatment occurred in a facility, you need those records available to verify care was rendered. A gap here is a common audit finding. Request records proactively and keep them in the claim file. |
| 7 | Talk to your compliance officer if your patient mix skews toward pulmonary disease comorbidities. The pulmonary exclusion is a hard stop in NCD 228. If your wound care patients frequently present with COPD or other pulmonary conditions, you need a documented screening protocol and a clear policy on how your team handles these cases. This isn't a gray area — loop in your compliance officer to make sure your process is airtight. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Air-Fluidized Beds Under NCD 228
NCD 228 does not list specific CPT, HCPCS Level II, or ICD-10-CM codes in the policy source document. This is not unusual for an NCD — code-level specificity is often handled at the Local Coverage Determination (LCD) or MAC contractor level.
For the HCPCS codes applicable to air-fluidized beds in your billing system, contact your DME MAC directly or reference the associated LCD in your MAC's coverage database. Your MAC may publish a related Article (formerly a Coverage Article) that lists the applicable HCPCS codes, required ICD-10 diagnosis codes, and documentation requirements that must accompany claims billed under NCD 228.
Do not bill without confirming code-level requirements with your MAC. Submitting claims with an unsupported HCPCS code — even when clinical criteria are met — is its own denial pathway.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.